BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 23132303)

  • 1. The complexity of prostate cancer: genomic alterations and heterogeneity.
    Boyd LK; Mao X; Lu YJ
    Nat Rev Urol; 2012 Nov; 9(11):652-64. PubMed ID: 23132303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
    Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
    Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
    Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
    Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and phenotypic heterogeneity in prostate cancer.
    Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S
    Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing.
    Wyatt AW; Mo F; Wang Y; Collins CC
    Asian J Androl; 2013 May; 15(3):301-8. PubMed ID: 23503423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.
    Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Grönberg H
    Eur Urol; 2013 Feb; 63(2):347-53. PubMed ID: 22502944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer.
    Kristiansen A; Bergström R; Delahunt B; Samaratunga H; Guðjónsdóttir J; Grönberg H; Egevad L; Lindberg J
    Prostate; 2019 Jun; 79(8):920-928. PubMed ID: 30908670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications.
    Gerlinger M; Catto JW; Orntoft TF; Real FX; Zwarthoff EC; Swanton C
    Eur Urol; 2015 Apr; 67(4):729-37. PubMed ID: 24836153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.
    VanderWeele DJ; Finney R; Katayama K; Gillard M; Paner G; Imoto S; Yamaguchi R; Wheeler D; Lack J; Cam M; Pontier A; Nguyen YTM; Maejima K; Sasaki-Oku A; Nakano K; Tanaka H; Vander Griend D; Kubo M; Ratain MJ; Miyano S; Nakagawa H
    Eur Urol Focus; 2019 May; 5(3):416-424. PubMed ID: 29398457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
    Wei L; Wang J; Lampert E; Schlanger S; DePriest AD; Hu Q; Gomez EC; Murakam M; Glenn ST; Conroy J; Morrison C; Azabdaftari G; Mohler JL; Liu S; Heemers HV
    Eur Urol; 2017 Feb; 71(2):183-192. PubMed ID: 27451135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent network effects along the axis of gene expression during prostate cancer progression.
    Charmpi K; Guo T; Zhong Q; Wagner U; Sun R; Toussaint NC; Fritz CE; Yuan C; Chen H; Rupp NJ; Christiansen A; Rutishauser D; Rüschoff JH; Fankhauser C; Saba K; Poyet C; Hermanns T; Oehl K; Moore AL; Beisel C; Calzone L; Martignetti L; Zhang Q; Zhu Y; Martínez MR; Manica M; Haffner MC; Aebersold R; Wild PJ; Beyer A
    Genome Biol; 2020 Dec; 21(1):302. PubMed ID: 33317623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5q21 deletion is often heterogeneous in prostate cancer.
    Kluth M; Al Kilani Z; Özden C; Hussein K; Frogh S; Möller-Koop C; Burandt E; Steurer S; Büscheck F; Jacobsen F; Luebke AM; Minner S; Tsourlakis MC; Hoeflmayer D; Wittmer C; Schlomm T; Sauter G; Simon R; Wilczak W
    Genes Chromosomes Cancer; 2019 Aug; 58(8):509-515. PubMed ID: 30623509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Emerging Landscape for Canonical and Actionable Molecular Alterations in Primary and Metastatic Prostate Cancer.
    Dawson NA; Zibelman M; Lindsay T; Feldman RA; Saul M; Gatalica Z; Korn WM; Heath EI
    Mol Cancer Ther; 2020 Jun; 19(6):1373-1382. PubMed ID: 32220973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
    Bostwick DG; Shan A; Qian J; Darson M; Maihle NJ; Jenkins RB; Cheng L
    Cancer; 1998 Nov; 83(9):1995-2002. PubMed ID: 9806659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genomic evolution of human prostate cancer.
    Mitchell T; Neal DE
    Br J Cancer; 2015 Jul; 113(2):193-8. PubMed ID: 26125442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrafocal heterogeneity of ERG protein expression and gene fusion pattern in prostate cancer.
    Suh JH; Park JH; Lee C; Moon KC
    Prostate; 2017 Oct; 77(14):1438-1445. PubMed ID: 28845585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.
    Wu Y; Schoenborn JR; Morrissey C; Xia J; Larson S; Brown LG; Qu X; Lange PH; Nelson PS; Vessella RL; Fang M
    J Mol Diagn; 2016 Jan; 18(1):131-43. PubMed ID: 26607774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.